Molecular diagnostics and its newly developed techniques for examining the molecular signatures of cancer cells--protein as well as gene patterns--offer great promise for revolutionizing our approaches to screening, diagnosis, and classification for many different kinds of cancer. Participation in the clinical trials that will validate these new approaches will lead to significant improvements in care for cancer patients in the not-too-distant future.
![Clinical Trials: Making the Future the Present](https://webarchive.library.unt.edu/eot2008/20081023100730im_/http://www.cancer.gov/images/Documents/abd6d05e-f179-4ec1-8376-6d4992583274/cancer44.jpg)
< Previous | Index |